Free Trial

Atea Pharmaceuticals (AVIR) SEC Filings & 10K Form

Atea Pharmaceuticals logo
$3.84 +0.10 (+2.54%)
As of 11:01 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Atea Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/24/2025
5:00 PM
Atea Pharmaceuticals (Issuer)
Berman Howard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2025
5:05 PM
Atea Pharmaceuticals (Issuer)
Berman Howard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM
Atea Pharmaceuticals (Issuer)
Lucidi Bruno (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM
Adams Jerome M. (Reporting)
Atea Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM
Atea Pharmaceuticals (Issuer)
Polsky Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM
Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM
Atea Pharmaceuticals (Issuer)
Duncan Barbara Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM
Atea Pharmaceuticals (Issuer)
Murphy Polly A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
4:16 PM
Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
5:21 PM
Atea Pharmaceuticals (Subject)
Sommadossi Jean-Pierre (Filed by)
Form SCHEDULE 13G/A
05/12/2025
3:45 PM
Atea Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2025
4:00 PM
Atea Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
7:14 PM
Atea Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/17/2025
11:23 AM
Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
Form SCHEDULE 13D/A
04/17/2025
7:06 AM
Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
3:50 PM
Atea Pharmaceuticals (Filer)
Form DEFA14A
04/01/2025
8:21 AM
Atea Pharmaceuticals (Filer)
Form DEFA14A
04/01/2025
8:19 AM
Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
4:15 PM
Atea Pharmaceuticals (Filer)
Form DEFA14A
03/26/2025
1:30 PM
Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
Form DFAN14A
03/24/2025
5:16 AM
Atea Pharmaceuticals (Filer)
Form DEFA14A
03/24/2025
5:10 AM
Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
10:58 AM
Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
Form SCHEDULE 13D/A
03/06/2025
3:45 PM
Atea Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
8:27 AM
Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
Form SCHEDULE 13D
02/24/2025
5:52 PM
Atea Pharmaceuticals (Issuer)
Kirsch Arthur S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:47 PM
Atea Pharmaceuticals (Issuer)
Kirsch Arthur S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/24/2025
7:17 AM
Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
11:47 AM
Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
5:00 PM
Atea Pharmaceuticals (Issuer)
Foster Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM
Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM
Atea Pharmaceuticals (Issuer)
Corcoran Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM
Atea Pharmaceuticals (Issuer)
Horga Maria Arantxa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM
Atea Pharmaceuticals (Issuer)
Vavricka John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM
Atea Pharmaceuticals (Issuer)
Hammond Janet MJ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
1:30 PM
Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
Form 4/A
01/17/2025
7:03 AM
Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
8:50 AM
Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13D
12/12/2024
5:00 PM
Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:17 PM
Atea Pharmaceuticals (Subject)
BERGER FRANKLIN M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
11:15 PM
Atea Pharmaceuticals (Filer)
Form EFFECT
Why AMZN, GOOG, MSFT might destroy NVDA (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
11/15/2024
9:34 AM
Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/07/2024
3:58 PM
Atea Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/07/2024
3:41 PM
Atea Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
3:27 PM
Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
7:02 PM
Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:22 PM
Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:09 PM
Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2024
3:16 PM
Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:45 PM
Atea Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:15 PM
Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AVIR) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners